Effects of two intermittent alendronate regimens in the prevention or treatment of postmenopausal osteoporosis

This publication has 24 references indexed in Scilit:

• Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral FracturesResults From the Fracture Intervention Trial
  JAMA, 1998
• Dose-Response Relationships for Alendronate Treatment in Osteoporotic Elderly Women
  Journal of Clinical Endocrinology & Metabolism, 1997
• Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
  The Lancet, 1996
• Adverse Effects of Bisphosphonates
  Drug Safety, 1996
• Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling
  The American Journal of Medicine, 1995
• The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
  Journal of Clinical Investigation, 1993
• Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis
  The American Journal of Medicine, 1993
• Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin
  Osteoporosis International, 1993
• Short-term effect of alendronate on bone mass and bone remodeling in postmenopausal women
  Osteoporosis International, 1993
• Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition
  Metabolic Bone Disease and Related Research, 1984